Amedisys Inc
(NAS:AMED)
$
91.41
0.18 (0.2%)
Market Cap: 2.99 Bil
Enterprise Value: 3.22 Bil
PE Ratio: 36.27
PB Ratio: 2.61
GF Score: 83/100 Amedisys Inc at Barclays Global Healthcare Conference Transcript
Mar 17, 2022 / 12:00PM GMT
Release Date Price:
$165.1
(+5.27%)
Sarah Elizabeth James
Barclays Bank PLC, Research Division - Research Analyst
Good morning, and thank you all for joining us. I'm Sarah James, emerging health care delivery model and provider analyst at Barclays. And we're really thrilled to have with us here today Amedisys. We've got pretty much the full management team here. We've got Chris Gerard, President and COO; Scott Ginn, EVP and CFO; and Nick Muscato, SVP of Finance. So thank you, guys, all for joining us here.
Scott G. Ginn
Amedisys, Inc. - Executive VP & CFO
Thank you for having us.
Christopher T. Gerard
Amedisys, Inc. - President, COO & Director
Thank you.
Questions & Answers
Sarah Elizabeth James;Christopher T. Gerard
Barclays Bank PLC, Research Division - Research Analyst;Amedisys, Inc. - President, COO & Director
So wanted to open up with some questions on big picture. How do you think about long-term growth developing over the next few years?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot